Pharmaxi: A European CRO Advancing Evidence-Based Clinical Research

As clinical development accelerates worldwide, companies working on medicines, medical devices, and diagnostics increasingly seek partners capable of managing research programs with precision and adaptability. Pharmaxi, a European contract research organization headquartered in Poland, has built its approach around one core principle: clinical evidence must be generated through well-planned, well-managed, and transparent research processes.

With operations in Poland, Ukraine, Pharmaxi supports sponsors throughout the full lifecycle of clinical projects. For organizations looking for trusted CRO clinical research expertise in Europe, Pharmaxi offers a balanced combination of scientific competence and operational discipline.

A Company Built Around Clinical Evidence Generation

Pharmaxi was founded in 2013 by two practicing physicians who saw the need for a CRO capable of simplifying complex clinical development tasks. Their vision shaped the company’s focus on projects that require rigorous planning and continuous oversight.

The team works on a full spectrum of evidence-generation activities, including:

• clinical trials in phases II–IV
• observational and epidemiological studies
• registries and post-marketing surveillance
• performance and safety studies for medical devices and IVDs

This breadth enables Pharmaxi to support early design decisions, operational execution, and post-approval evidence in a single integrated framework.

Structured Clinical Operations Supported by Local Expertise

Pharmaxi’s operational model centers on tailoring its procedures to the specifics of every research project. Instead of relying on rigid templates, the company develops customized project documentation that outlines workflows, responsibilities, risk considerations, and communication processes.

Core operational capabilities include:

• study design input and protocol refinement
• submissions to regulatory authorities and ethics committees
• on-site and remote monitoring in Poland, Ukraine, and other European regions
• management of Trial Master File (TMF) documentation

Because the team understands regional regulatory pathways, sponsors benefit from accurate timelines, predictable start-up phases, and consistent interactions with investigators.

Data-Focused Services Supporting Modern Research Needs

Alongside clinical operations, Pharmaxi maintains strong in-house data management and biometrics departments — essential components of any CRO clinical research service.

Data Management

• database and eCRF design
• data validation plan development
• discrepancy review and cleaning
• medical coding (MedDRA)

Biostatistics

• determination of sample size requirements
• statistical analysis planning
• programming in R
• preparation of statistical outputs for clinical study report

This data-centric approach ensures that evidence generated in Pharmaxi-supported studies meets the requirements of regulators, auditors, and scientific reviewers.

Experience Across Multiple Therapeutic Areas

Over the past decade, Pharmaxi has completed clinical and observational studies in more than a dozen therapeutic areas, such as:

• cardiology
• oncology
• endocrinology
• pediatrics
• gastroenterology
• neurology
• pulmonology
• orphan diseases

This experience allows the team to work effectively with diverse investigator networks and to adapt to the clinical routines of various specialties.

A Flexible European CRO for Agile Clinical Development

One of Pharmaxi’s defining strengths is its flexible collaboration model. Sponsors can choose full-service support or rely on the company to manage only selected functions. For smaller pharmaceutical and biotech organizations, this adaptability helps reduce operational burden while maintaining high scientific standards.

Pharmaxi also works with trusted subcontractors for services that fall outside its internal infrastructure — such as drug logistics, storage, insurance, or courier operations — ensuring a smooth end-to-end process without requiring the sponsor to manage multiple vendors.

A Reliable Partner for Evidence-Driven Research

From its beginnings as a physician-led initiative to its current role supporting sponsors from 21 countries, Pharmaxi has grown into an experienced and dependable CRO with a strong European presence. Its work is grounded in practical feasibility assessment, structured project oversight, and respect for the scientific and regulatory frameworks that govern clinical research.

For organizations searching for a committed and knowledgeable partner in cro clinical research, Pharmaxi provides an approach that unites technical expertise with clear communication and operational transparency.